MIY is found in 11 entries

MIY as free ligands, exist in 11 entries. Examples include 2DRD, 2WQ5, 2XPV

Find related ligands: Stereoisomers Similar ligands Chemical Structure Search

View summary at Ligand Expo

Chemical Component Summary

Identifiers (4S,4aS,5aR,12aS)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide
Formula C23 H27 N3 O7
Molecular Weight 457.48 g/mol
Type non-polymer
Isomeric SMILES CN(C)[C@H]1[C@@H]2C[C@@H]3Cc4c(ccc(O)c4C(=O)C3=C(O)[C@]2(O)C(=O)C(C(N)=O)=C1O)N(C)C
InChI InChI=1S/C23H27N3O7/c1-25(2)12-5-6-13(27)15-10(12)7-9-8-11-17(26(3)4)19(29)16(22(24)32)21(31)23(11,33)20(30)14(9)18(15)28/h5-6,9,11,17,27,29-30,33H,7-8H2,1-4H3,(H2,24,32)/t9-,11-,17-,23-/m0/s1

Chemical Details

Formal Charge 0
Atom Count 60
Chiral Atom Count 4
Chiral Atoms C4 C5 C18 C7
Bond Count 63
Aromatic Bond Count 6

Drug Info: DrugBank

DrugBank ID DB01017   (Stereoisomeric match)
Name Minocycline
  • approved
  • investigational
Description A tetracycline analog, having a 7-dimethylamino and lacking the 5 methyl and hydroxyl groups, which is effective against tetracycline-resistant staphylococcus infections. [PubChem]
  • (4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide
  • 7-Dimethylamino-6-demethyl-6-deoxytetracycline
  • Minociclina
  • Minociclinum
  • Minocyclin
  • Minocyclinum
Salts Minocycline Hydrochloride
Brand Names
  • Apo-minocycline Cap 100mg
  • Apo-minocycline Cap 50mg
  • Arestin
  • Arestin Microspheres
  • Dom-minocycline Capsules
  • Dynacin
  • Enca 100mg
  • Enca 50mg
  • Minocin
  • Minocin Cap 100mg
  • Minocin Cap 50mg
  • Minocin Kit
  • Minocycline
  • Minocycline Hydrochloride
  • Minocycline-100
  • Minocycline-50
  • Mylan-minocycline
  • Nu-minocycline
  • PHL-minocycline
  • PMS-minocycline
  • Ran-minocycline
  • Ratio-minocycline
  • Riva-minocycline
  • Riva-minocycline 50 mg
  • Sandoz Minocycline
  • Solodyn
  • Teva-minocycline
  • Ximino
  • Aknemin
  • Apo-Minocycline
  • Klinomycin
  • Minoderm
  • Minomycin
  • Minopen
  • Minox
  • Minoz
  • Vectrin
Affected Organism Enteric bacteria and other eubacteria
Indication For the treatment of infections caused by susceptible strains of microorganisms, such as Rocky Mountain spotted fever, typhus fever and the typhus group, Q fever, rickettsial pox and tick fevers caused by Rickettsiae, upper respiratory tract infections caused by Streptococcus pneumoniae and for the treatment of asymptomatic carriers of Neisseria meningitidis.
Pharmacology Minocycline, the most lipid soluble and most active tetracycline antibiotic, is, like doxycycline, a long-acting tetracycline. Minocycline's effects are related to the inhibition of protein synthesis. Although minocycline's broader spectrum of activity, compared to other members of the group, includes activity against Neisseria meningitidis, its use as a prophylaxis is no longer recomended because of side effects (dizziness and vertigo). Current research is examining the possible neuroprotective effects of minocycline against progression of Huntington's Disease, an inherited neurodegenerative disorder. The neuroprotective action of minocycline may include its inhibitory effect on 5-lipoxygenase, an inflammatory enzyme associated with brain aging.
Mechanism of action Minocycline passes directly through the lipid bilayer or passively diffuses through porin channels in the bacterial membrane. Tetracyclines like minocycline bind to the 30S ribosomal subunit, preventing the binding of tRNA to the mRNA-ribosome complex and interfering with protein synthesis.
Route of administration
  • intravenous
  • oral
  • subgingival
  • Anti-Bacterial Agents
  • Tetracyclines
  • A01AB23
  • J01AA08
AHFS-Code 08:12.24
CAS number 10118-90-8
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID: 21059682